ReviewReproductive sciences (Thousand Oaks, Calif.)2022

The Prediction of Recurrence in Low-Risk Endometrial Cancer: Is It Time for a Paradigm Shift in Adjuvant Therapy?

Mohamed Laban et al.PubMed ↗Publisher ↗

No numbers read from the abstract.